A 12 -year -old boy with a rare, painful Skin condition Finally, to play football and ride your bike, more freedom has been given New clinical test.
Gabriyas suffers from Misurankov Reconsideration dystrophic epidermolisis bullosa (RDEB) Since he was a child.
Inflammatory disease is severely weakened, and with it people have extremely delicate skin that is easily damaged, causing blistering, deep wounds and stains.
Only 150 children in the UK are affected only by genetic disease, but due to no treatment available, symptoms are managed to prepare wounds and apply eye ointments.
So when Gabriyus was given a chance to appear in a clinical test at the Great Ormand Street (GOSH), he jumped on the occasion.
He said, “I wanted to participate in the test because I was excited to see if it could help improve my situation and so I can do more things that I like, such as playing football and spending time with my friends,” he said.
The young man, who can speak three languages and is a big fan of footballer Lionel Messi, needs to be replaced three times a day, or more if he was injured.
But since the test, he has managed to do some things that he was unable to do before treatment, in which he was able to attend some sports in school, ride his bike in the park on grass, and play football with his friends with a soft ball.
His mother, Jolita Sekivisin said: “Gabriyus really did well. His wounds healed quickly, and their skin became less red and swollen.
“Their skin was also less itchy, which also reduced their scratches. Their sleep was also less upset because they did not need to change their special wounds often, so it was a huge benefit.”
Ms. Sekavisin said the test has given her son more freedom than before, but she still needs to be careful to be careful in any activity or to avoid falling.
Gabriyus was referred to as a child, when he was born, when he was looking at a wound, and when he was two weeks, he was detected RDEB.
Over time, the condition can lead to serious complications and in many patients with conditions, a type of skin cancer called squamous cell carcinoma can develop when they are young adults – this is the most common cause of death for RDEB patients.
Ms. Sekivisin said: “The first two years were really difficult because you had to see her continuously – even rubbing her eyes can cause painful blisters.
“He could not even tell us how much he was hurting or where he was hurting.”
Gabriyus is one of the 30 children, who participated in the new clinical trial at Gosh and Birmingham Children’s Hospitals, in which they received some stem cells through an intravenous drip.
In testing, Medics evaluated whether regular infections with mesencimal stromal cells (MSc) have improved symptoms for children with condition, after studies it was suggested that this treatment could promote wound healing, reduce inflammation and stimulate tissue regeneration.
The patients go to the hospital and have a drip that protects cells more than 10 to 15 minutes.
In the trial, NHS England, National Institute for Health and Care Research and Charity Cure EBs funded by EB, children were given treatment called Cordstrom, produced by Inmunbio.
Inmunebio has agreed to provide cordstrom free for all children participating in the test, so researchers continue to study them, and patients are expected to have two infections of treatment every four months.
The company is demanding regulatory approval for treatment to be approved for use in UK and other countries.